ROBIN L. SMITH, M.D.

Corporate Board Profile

Tech Score: 0/100

Emmaus Life Sciences, Inc.

Filing Date	Source Excerpt
2016-10-06	Robin L. Smith, M.D. joined our Board of Directors as its Chairman on August 20, 2015. ... Dr. Smith has been the Chairman of the Board since August 20, 2015. ... The following table ... Robin Smith 2016 Option Awards 236,800 Stock Awards 265,500 Total 502,300
2017-07-27	Robin L. Smith, M.D. joined our Board of Directors as its Chairman on August 20, 2015. Dr. Robin L. Smith is a global thought leader in the regenerative medicine industry... During our fiscal year ended September 30, 2016, non-employee directors did not receive any cash compensation but did receive fully vested grants of Common Stock, Restricted Stock and options to purchase Common Stock for their service on our Board of Directors or committees thereof... Robin Smith Option Awards ($) 236,800, Stock Awards ($) 265,500, Total ($) 502,300.
2018-03-01	Robin L. Smith, M.D. joined our Board of Directors as its Chairman on August 20, 2015. Dr. Robin L. Smith is a global thought leader in the regenerative medicine industry... Dr. Smith is also entitled to the following awards... Dr. Smith will be entitled to an annual cash fee of $300,000... As of September 30, 2017, Dr. Smith had earned $225,000 of the Annual Fee... Dr. Smith has received, or will be entitled to receive, the following equity awards... The aggregate number of option awards outstanding for Dr. Smith at September 30, 2017 was 166,250 shares... Director Compensation―Fiscal Year Ended September 30, 2017: Robin Smith (1) Fees Earned or Paid in Cash ($) 225,000 Option Awards ($) 520,300 Stock Awards ($) 108,250 All Other Compensation ($) 364,537 Total ($) 1,218,087.

LISATA THERAPEUTICS, INC.

Filing Date	Source Excerpt
2012-09-07	Since 2006, Dr. Smith has also served as Chief Executive Officer and Chairman of the Board. Dr. Robin L. Smith became the Chief Executive Officer and Chairman of the Board of NeoStem effective June 2, 2006. The Board of Directors concluded that Dr. Smith should continue serving as a director based upon her expertise in business development and medicine, including her extensive and diversified experience serving in executive and board capacities in medical enterprises and healthcare-based entities, and her leadership of the Company over the past six years.
2013-08-30	Dr. Robin L. Smith became the Chief Executive Officer and Chairman of the Board of NeoStem effective June 2, 2006... Dr. Smith's expertise in business development and medicine includes her extensive and diversified experience... Since 2006, she has served as chairman and CEO of NeoStem... The Board of Directors has determined that Dr. Smith is CEO and Chairman of the Board... The Summary Compensation Table shows total compensation of $1,643,403 for 2012.

Filing Date

Source Excerpt

2012-09-07

Since 2006, Dr. Smith has also served as Chief Executive Officer and Chairman of the Board. Dr. Robin L. Smith became the Chief Executive Officer and Chairman of the Board of NeoStem effective June 2, 2006. The Board of Directors concluded that Dr. Smith should continue serving as a director based upon her expertise in business development and medicine, including her extensive and diversified experience serving in executive and board capacities in medical enterprises and healthcare-based entities, and her leadership of the Company over the past six years.

2013-08-30

Dr. Robin L. Smith became the Chief Executive Officer and Chairman of the Board of NeoStem effective June 2, 2006... Dr. Smith's expertise in business development and medicine includes her extensive and diversified experience... Since 2006, she has served as chairman and CEO of NeoStem... The Board of Directors has determined that Dr. Smith is CEO and Chairman of the Board... The Summary Compensation Table shows total compensation of $1,643,403 for 2012.

Data sourced from SEC filings. Last updated: 2026-02-03